Financial reports
Current reports
6-K
Notice of Meeting and Record Date
9 Apr 24
6-K
Curaleaf to Report First Quarter 2024 Financial and Operational Results
4 Apr 24
6-K
Curaleaf to Acquire Northern Green Canada to Bolster European Flower Supply
19 Mar 24
6-K
Current report (foreign)
13 Feb 24
6-K
Curaleaf International Acquires Can4Med, Expanding Presence in Poland’s Growing Medical Cannabis Market
13 Feb 24
6-K
Curaleaf Celebrates Launch of Adult Use Sales at Hudson Valley, NY Dispensary
26 Jan 24
6-K
Curaleaf Announced Reorganization of its U.S. Operations in Connection with TSX Listing
19 Dec 23
6-K
Monthly Progress Report
8 Dec 23
6-K
Unaudited Condensed Interim Consolidated Financial Statements
13 Nov 23
6-K
Monthly Progress Report
9 Nov 23
Registration and prospectus
F-X
Appointment of agent for service of process by issuers registering securities
3 Jan 23
F-10
Registration of securities (Canada)
3 Jan 23
D
$135.7M in debt, sold $135.7M, 15 investors
30 Dec 21
S-8
Registration of securities for employees
13 Nov 20
F-10/A
Registration of securities (Canada) (amended)
2 Nov 20
F-10/A
Registration of securities (Canada) (amended)
30 Oct 20
F-X
Appointment of agent for service of process by issuers registering securities
25 Sep 20
F-10
Registration of securities (Canada)
25 Sep 20
D
$14.04M in equity / securities to be acquired, sold $14.04M, 36 investors
18 Jun 19
D
$8.36M in equity / securities to be acquired, sold $8.36M, 3 investors
18 Jun 19
Proxies
No filings